Maball 500 Injection

Product Description

Maball 500mg Injection acts as a monoclonal antibody. This drug is relatively new and is used to offer targeted therapy to treat cancer. Maball 500mg Injection only targets cancer cells in the body, thus the drug is less harmful as compared to Maball 500mg Injection radiation treatment.

Maball 500mg Injection is used to treat chronic lymphocytic leukemia and some types of non-hodgkins lymphoma.

The first dose of Maball 500mg Injection is given through an IV for about 6 hours. The time period of administering the dose may be reduced afterwards. Maball 500mg Injection is not available in the form of a tablet or pill. The dosage is determined by the doctor as per the patients health, age, weight, severity of the cancer and the bodys reaction to the drug.

Key Features of Maball 500 Injection

Maball 500 Injection stands out for its use of Rituximab, an effective ingredient in cancer therapy, supplied in a ready-to-administer liquid form. With its standardized 500mg/50ml dosage, the injection is designed for precision and ease of administration. This product is suitable for all patients as recommended by medical professionals and is supplied by trusted exporters and traders in India. Ensure proper storage in a cool, dry place to preserve its quality.


Therapeutic Advantages of Rituximab

Rituximab, the active ingredient in Maball 500 Injection, targets specific cells involved in cancer, making it a valuable agent in the treatment of lymphomas and leukemias. Its targeted mechanism of action helps reduce disease progression, offering improved patient outcomes. The treatment should be administered by healthcare professionals to ensure safety and efficacy.